255 related articles for article (PubMed ID: 30871809)
1. Annexin-A1 - A Blessing or a Curse in Cancer?
Foo SL; Yap G; Cui J; Lim LHK
Trends Mol Med; 2019 Apr; 25(4):315-327. PubMed ID: 30871809
[TBL] [Abstract][Full Text] [Related]
2. Inflammation and cancer: role of annexin A1 and FPR2/ALX in proliferation and metastasis in human laryngeal squamous cell carcinoma.
Gastardelo TS; Cunha BR; Raposo LS; Maniglia JV; Cury PM; Lisoni FC; Tajara EH; Oliani SM
PLoS One; 2014; 9(12):e111317. PubMed ID: 25490767
[TBL] [Abstract][Full Text] [Related]
3. Annexin A1 Expression Is Associated with Epithelial-Mesenchymal Transition (EMT), Cell Proliferation, Prognosis, and Drug Response in Pancreatic Cancer.
Oshi M; Tokumaru Y; Mukhopadhyay S; Yan L; Matsuyama R; Endo I; Takabe K
Cells; 2021 Mar; 10(3):. PubMed ID: 33804148
[TBL] [Abstract][Full Text] [Related]
4. Cisplatin treatment modulates Annexin A1 and inhibitor of differentiation to DNA 1 expression in cervical cancer cells.
Prates J; Moreli JB; Gimenes AD; Biselli JM; Pires D'Avila SCG; Sandri S; Farsky SHP; Rodrigues-Lisoni FC; Oliani SM
Biomed Pharmacother; 2020 Sep; 129():110331. PubMed ID: 32768930
[TBL] [Abstract][Full Text] [Related]
5. Annexin A1: A Bane or a Boon in Cancer? A Systematic Review.
Ganesan T; Sinniah A; Ibrahim ZA; Chik Z; Alshawsh MA
Molecules; 2020 Aug; 25(16):. PubMed ID: 32823805
[TBL] [Abstract][Full Text] [Related]
6. Annexin A1 is involved in the acquisition and maintenance of a stem cell-like/aggressive phenotype in prostate cancer cells with acquired resistance to zoledronic acid.
Bizzarro V; Belvedere R; Milone MR; Pucci B; Lombardi R; Bruzzese F; Popolo A; Parente L; Budillon A; Petrella A
Oncotarget; 2015 Sep; 6(28):25076-92. PubMed ID: 26312765
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
Luthra R; Singh RR; Luthra MG; Li YX; Hannah C; Romans AM; Barkoh BA; Chen SS; Ensor J; Maru DM; Broaddus RR; Rashid A; Albarracin CT
Oncogene; 2008 Nov; 27(52):6667-78. PubMed ID: 18663355
[TBL] [Abstract][Full Text] [Related]
8. Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells.
de Graauw M; van Miltenburg MH; Schmidt MK; Pont C; Lalai R; Kartopawiro J; Pardali E; Le Dévédec SE; Smit VT; van der Wal A; Van't Veer LJ; Cleton-Jansen AM; ten Dijke P; van de Water B
Proc Natl Acad Sci U S A; 2010 Apr; 107(14):6340-5. PubMed ID: 20308542
[TBL] [Abstract][Full Text] [Related]
9. Annexin A1 is involved in resistance to 5-FU in colon cancer cells.
Onozawa H; Saito M; Saito K; Kanke Y; Watanabe Y; Hayase S; Sakamoto W; Ishigame T; Momma T; Ohki S; Takenoshita S
Oncol Rep; 2017 Jan; 37(1):235-240. PubMed ID: 27840982
[TBL] [Abstract][Full Text] [Related]
10. miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome Editing.
Belvedere R; Saggese P; Pessolano E; Memoli D; Bizzarro V; Rizzo F; Parente L; Weisz A; Petrella A
Int J Mol Sci; 2018 Jul; 19(7):. PubMed ID: 29986379
[TBL] [Abstract][Full Text] [Related]
11. Annexin A1 regulates EGFR activity and alters EGFR-containing tumour-derived exosomes in head and neck cancers.
Raulf N; Lucarelli P; Thavaraj S; Brown S; Vicencio JM; Sauter T; Tavassoli M
Eur J Cancer; 2018 Oct; 102():52-68. PubMed ID: 30142511
[TBL] [Abstract][Full Text] [Related]
12. PPARγ Ligand-induced Annexin A1 Expression Determines Chemotherapy Response via Deubiquitination of Death Domain Kinase RIP in Triple-negative Breast Cancers.
Chen L; Yuan Y; Kar S; Kanchi MM; Arora S; Kim JE; Koh PF; Yousef E; Samy RP; Shanmugam MK; Tan TZ; Shin SW; Arfuso F; Shen HM; Yang H; Goh BC; Park JI; Gaboury L; Lobie PE; Sethi G; Lim LHK; Kumar AP
Mol Cancer Ther; 2017 Nov; 16(11):2528-2542. PubMed ID: 29021293
[TBL] [Abstract][Full Text] [Related]
13. Enhanced antitumor effect of combination of annexin A1 knockdown and bortezomib treatment in multiple myeloma in vitro and in vivo.
Jia C; Kong D; Guo Y; Li L; Quan L
Biochem Biophys Res Commun; 2018 Nov; 505(3):720-725. PubMed ID: 30292410
[TBL] [Abstract][Full Text] [Related]
14. Effect of Annexin A1 gene on the proliferation and invasion of esophageal squamous cell carcinoma cells and its regulatory mechanisms.
Han G; Lu K; Huang J; Ye J; Dai S; Ye Y; Zhang L
Int J Mol Med; 2017 Feb; 39(2):357-363. PubMed ID: 28035369
[TBL] [Abstract][Full Text] [Related]
15. Correlation of ANXA1 expression with drug resistance and relapse in bladder cancer.
Yu S; Meng Q; Hu H; Zhang M
Int J Clin Exp Pathol; 2014; 7(9):5538-48. PubMed ID: 25337195
[TBL] [Abstract][Full Text] [Related]
16. The role of annexin A1 in expression of matrix metalloproteinase-9 and invasion of breast cancer cells.
Kang H; Ko J; Jang SW
Biochem Biophys Res Commun; 2012 Jun; 423(1):188-94. PubMed ID: 22640735
[TBL] [Abstract][Full Text] [Related]
17. Potential role of Anxa1 in cancer.
Guo C; Liu S; Sun MZ
Future Oncol; 2013 Nov; 9(11):1773-93. PubMed ID: 24156336
[TBL] [Abstract][Full Text] [Related]
18. An overview of the regulatory role of annexin A1 in the tumor microenvironment and its prospective clinical application (Review).
Gao K; Li X; Luo S; Zhao L
Int J Oncol; 2024 May; 64(5):. PubMed ID: 38516766
[TBL] [Abstract][Full Text] [Related]
19. ANXA1 inhibits miRNA-196a in a negative feedback loop through NF-kB and c-Myc to reduce breast cancer proliferation.
Yuan Y; Anbalagan D; Lee LH; Samy RP; Shanmugam MK; Kumar AP; Sethi G; Lobie PE; Lim LH
Oncotarget; 2016 May; 7(19):27007-20. PubMed ID: 27105503
[TBL] [Abstract][Full Text] [Related]
20. Annexin A1 as a Regulator of Immune Response in Cancer.
Araújo TG; Mota STS; Ferreira HSV; Ribeiro MA; Goulart LR; Vecchi L
Cells; 2021 Aug; 10(9):. PubMed ID: 34571894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
